Dr. Bethany Davis, M.D

NPI: 1881763001
Total Payments
$8,118
2023 Payments
$3,959
Companies
15
Transactions
83

Payment Breakdown by Category

Food & Beverage$2,784 (34.3%)
Travel$2,730 (33.6%)
Consulting$1,800 (22.2%)
Research$804.18 (9.9%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $2,784 64 34.3%
Travel and Lodging $2,730 11 33.6%
Consulting Fee $1,800 1 22.2%
Unspecified $804.18 7 9.9%

Payments by Type

General
$7,313
76 transactions
Research
$804.18
7 transactions

Top Paying Companies

Company Total Records Latest Year
Neurocrine Biosciences, Inc. $2,040 14 $0 (2023)
AbbVie Inc. $1,800 1 $0 (2023)
Allergan Inc. $1,631 20 $0 (2018)
Avanir Pharmaceuticals, Inc. $1,304 11 $0 (2019)
Alkermes, Inc. $351.74 4 $0 (2018)
Takeda Pharmaceuticals U.S.A., Inc. $220.37 3 $0 (2019)
Lundbeck LLC $217.35 14 $0 (2021)
ACADIA Pharmaceuticals Inc $114.36 1 $0 (2017)
Otsuka America Pharmaceutical, Inc. $108.92 2 $0 (2021)
ITI, Inc. $102.20 2 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2023 $3,959 18 Neurocrine Biosciences, Inc. ($2,040)
2021 $53.09 3 Lundbeck LLC ($35.77)
2020 $16.76 1 Lundbeck LLC ($16.76)
2019 $1,399 13 Avanir Pharmaceuticals, Inc. ($1,304)
2018 $2,078 30 Allergan Inc. ($1,612)
2017 $612.23 18 Alkermes, Inc. ($123.48)

All Payment Transactions

83 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
05/29/2023 ITI, Inc. CAPLYTA (Drug) Food and Beverage In-kind items and services $81.15 General
Category: PSYCHIATRY
04/20/2023 AbbVie Inc. VRAYLAR (Drug) Consulting Fee Cash or cash equivalent $1,800.00 General
Category: NEUROSCIENCE
02/13/2023 ITI, Inc. CAPLYTA (Drug) Food and Beverage In-kind items and services $21.05 General
Category: PSYCHIATRY
02/07/2023 Stryker Corporation PREVALON (Device) Food and Beverage In-kind items and services $16.42 General
Category: MEDICAL
02/05/2023 Neurocrine Biosciences, Inc. Travel and Lodging Cash or cash equivalent $65.01 General
02/05/2023 Neurocrine Biosciences, Inc. Food and Beverage Cash or cash equivalent $44.58 General
02/04/2023 Neurocrine Biosciences, Inc. Food and Beverage In-kind items and services $71.66 General
02/04/2023 Neurocrine Biosciences, Inc. Food and Beverage In-kind items and services $49.79 General
02/04/2023 Neurocrine Biosciences, Inc. Food and Beverage In-kind items and services $26.06 General
02/03/2023 Neurocrine Biosciences, Inc. Travel and Lodging Cash or cash equivalent $360.47 General
02/03/2023 Neurocrine Biosciences, Inc. Food and Beverage In-kind items and services $140.15 General
02/03/2023 Neurocrine Biosciences, Inc. Food and Beverage In-kind items and services $97.94 General
02/03/2023 Neurocrine Biosciences, Inc. Food and Beverage In-kind items and services $58.70 General
02/03/2023 Neurocrine Biosciences, Inc. Food and Beverage In-kind items and services $49.79 General
02/02/2023 Neurocrine Biosciences, Inc. Travel and Lodging Cash or cash equivalent $360.47 General
02/02/2023 Neurocrine Biosciences, Inc. Food and Beverage In-kind items and services $138.44 General
02/01/2023 Neurocrine Biosciences, Inc. Travel and Lodging Cash or cash equivalent $387.21 General
02/01/2023 Neurocrine Biosciences, Inc. Travel and Lodging Cash or cash equivalent $189.75 General
09/17/2021 Lundbeck LLC BRINTELLIX (Drug) Food and Beverage Cash or cash equivalent $22.13 General
Category: PSYCHIATRY
06/11/2021 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $13.64 General
Category: PSYCHIATRY
03/05/2021 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $17.32 General
Category: PSYCHIATRY
12/04/2020 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $16.76 General
Category: PSYCHIATRY
09/18/2019 Otsuka Pharmaceutical Development & Commercialization, Inc. Food and Beverage In-kind items and services $80.45 General
08/06/2019 Avanir Pharmaceuticals, Inc. Travel and Lodging In-kind items and services $43.53 General
08/06/2019 Avanir Pharmaceuticals, Inc. Food and Beverage In-kind items and services $17.04 General

Research Studies & Clinical Trials

Study Name Company Amount Records
Phase IIA US POP w SOD 3125-201-002 Allergan Inc. $804.18 7

About Dr. Bethany Davis, M.D

Dr. Bethany Davis, M.D is a Psychiatry healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1881763001.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bethany Davis, M.D has received a total of $8,118 in payments from pharmaceutical and medical device companies, with $3,959 received in 2023. These payments were reported across 83 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($2,784).

Practice Information

  • Specialty Psychiatry
  • Location Atlanta, GA
  • Active Since 11/06/2006
  • Last Updated 05/29/2024
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1881763001

Products in Payments

  • VRAYLAR (Drug) $2,211
  • REXULTI (Drug) $161.37
  • NUPLAZID (Drug) $114.36
  • CAPLYTA (Drug) $102.20
  • MYDAYIS (Drug) $51.76
  • TRINTELLIX (Drug) $51.17
  • Trintellix (Drug) $48.90
  • Trulance (Drug) $45.88
  • BRINTELLIX (Drug) $22.13
  • PREVALON (Device) $16.42

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in Atlanta